600056 Stock Overview
Engages in the pharmaceutical business in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
China Meheco Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥11.67 |
| 52 Week High | CN¥13.88 |
| 52 Week Low | CN¥9.47 |
| Beta | 0.13 |
| 1 Month Change | -5.20% |
| 3 Month Change | 19.45% |
| 1 Year Change | 5.71% |
| 3 Year Change | 41.82% |
| 5 Year Change | 28.54% |
| Change since IPO | 22.20% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600056 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | -3.2% | -2.2% | -1.2% |
| 1Y | 5.7% | -7.7% | 11.8% |
Return vs Industry: 600056 exceeded the CN Healthcare industry which returned -7.7% over the past year.
Return vs Market: 600056 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 600056 volatility | |
|---|---|
| 600056 Average Weekly Movement | 6.3% |
| Healthcare Industry Average Movement | 8.3% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 600056 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600056's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 8,389 | Huidong Hu | www.meheco.com |
China Meheco Group Co., Ltd. engages in the pharmaceutical business in China and internationally. The company exports and imports natural medicines, pharmaceutical chemicals, medical equipment, and health products; produces and distributes pharmaceutical and health care products; and operates retail chain pharmacies. Its products include bulk pharmaceutical chemicals antibiotic fermentation and chemical synthesis tablets, injections, capsules, etc.; antibiotics; medicines for the treatment of cardio-cerebrovascular diseases, chronic diseases, and diabetes; antiviral; anti-infectious agents; gastrointestinal drugs; non-steroidal anti-inflammatory drugs; anti-allergic agents; specialty botanicals; western medicine preparations; Chinese patent medicines and herbal pieces; medical equipment and supplies; biological products; chemical raw materials; and nutritional and healthcare products.
China Meheco Group Co., Ltd. Fundamentals Summary
| 600056 fundamental statistics | |
|---|---|
| Market cap | CN¥17.46b |
| Earnings (TTM) | CN¥901.08m |
| Revenue (TTM) | CN¥35.13b |
19.4x
P/E Ratio0.5x
P/S RatioIs 600056 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600056 income statement (TTM) | |
|---|---|
| Revenue | CN¥35.13b |
| Cost of Revenue | CN¥31.29b |
| Gross Profit | CN¥3.84b |
| Other Expenses | CN¥2.94b |
| Earnings | CN¥901.08m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.60 |
| Gross Margin | 10.92% |
| Net Profit Margin | 2.57% |
| Debt/Equity Ratio | 41.0% |
How did 600056 perform over the long term?
See historical performance and comparisonDividends
1.8%
Current Dividend Yield39%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 09:49 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
China Meheco Group Co., Ltd. is covered by 12 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Bo Chen | Chasing Securities |
| Bin Wu | China Merchants Securities Co. Ltd. |